Results 391 to 398 of about 2,974,682 (398)

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Christina Lacchetti, Michael B Atkins, Ian Chau   +2 more
exaly  

Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV‐1 replication

AIDS (London), 1995
J. Angel, B. Saget, S. Walsh, T. Greten, C. Dinarello, P. Skolnik, S. Endres   +6 more
semanticscholar   +1 more source

Phosphodiesterase Inhibitors

2012
openaire   +1 more source

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

[Phosphodiesterase-3 inhibitor].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Yoshiaki, Kawagoe, Yoshiyuki, Hattori, Kikuo, Kasai   +2 more
openaire   +1 more source

Phosphodiesterase Inhibitors (PDEIs)

2009
openaire   +1 more source

Selective phosphodiesterase inhibitors

2010
openaire   +1 more source

Novel phosphodiesterase inhibitors.

1999
openaire   +1 more source